You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨斥資7.69億控股和仁科技 通策醫療(600763.SH)大跌逾9%
格隆匯5月16日丨“牙科茅”通策醫療(600763.SH)今日低開低走,現大跌逾9%,領跌滬深300成分股,報123.76元,最新總市值397億元。通策醫療昨晚公吿,與磐源投資簽署《股份轉讓協議》,擬通過支付現金方式受讓和仁科技約7879萬股股份,佔其股份總數的29.75%,交易金額7.69億元,與此同時磐源投資放棄剩餘持股的表決權。交易完成後,通策醫療將成為和仁科技第一大股東。對該筆交易不少股民有點“慌”,擔心通策成為接盤俠,和仁科技過去三年業績持續下滑,實控人又陷入股權質押危機。就在此前一天,和仁科技剛剛終止跟前任買家科學城(廣州)信息科技集團的交易,轉手就找到了通策醫療。此外,和仁科技主做醫療信息系統,與通策醫療協同性一般。值得注意的是,2021年通策醫療淨利潤為7.03億元,此次收購對價7.69億差不多是其去年全年淨利潤。另外,收購全部用現金支付,根據通策醫療2022年一季報,截至2022年3月末,通策醫療賬面貨幣資金為7.34億元,較2021年末減少了約1.1億元,用於支付收購對價耗光現金還略有差距。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account